MedPath

Evaluation of improvement of sleep quality by ingestion of an asparagus stem extract (ETAS50)

Not Applicable
Conditions
Decrease in sleep quality
Registration Number
JPRN-UMIN000052913
Lead Sponsor
AMINO UP Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

-BMI of 25 or higher (body mass index of 1 or higher) and Epworth sleepiness scale (evaluation of sleepiness) of 11 or higher. -Those who have good sleep phase, quality, and quantity (phase: 9 points or more, quality: 11 points or more, quantity: 9 points or more) on the 3D Sleep Scale (3DSS), and who score less than 6 points for sleep disturbance on the Pittsburgh Sleep Questionnaire (PSQI-J). -Morningness/eveningness diagnosis (morning/evening type) with a clear morningness (70-86 points) or clear eveningness (16-30 points). -Those who have an excessive*1 smoking habit. -Heavy drinker of alcohol*2 -Heavy drinkers*3 of caffeine-containing beverages and those who habitually consume caffeine-containing beverages within 4 hours before bedtime. -Those who have severe anemia, circulatory disease, respiratory disease, liver disease, renal disease, gastrointestinal disease, diabetes, rheumatoid arthritis, acute infectious disease, psychiatric disease, cerebrovascular disease, benign prostatic hyperplasia, frequent urination at night, symptoms of overactive bladder, etc. -Those who are receiving treatment for insomnia or sleep disorders. -Persons with serious drug or food allergies -Patients who are regularly using medications prescribed by a physician that are thought to affect sleep. -Persons enrolled in other clinical trials. -Other subjects deemed unsuitable by the principal investigator. *1: More than 20 cigarettes per day on average *2: Alcohol: An average of more than 60 g of the equivalent of pure alcohol per day, for example, 3 medium beer bottles (about 3 long cans 500 mL x 3), a little less than 3 gou of sake (180 mL x 3), 1+1/2 glasses (about 300 mL) of 25% shochu, 3 double glasses (about 180 mL) of whiskey, a little less than 6 glasses (about 600 mL) of wine, 3 cans (about 350 mL x 3) of canned chuhai with 7% alcohol *3: Coffee: An average of more than 3 cups (237 mL/cup x 3) in a mug per day

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sleep electroencephalogram measurement -Sleep quality related indexes: sleep efficiency, arousal index, sleep onset latency, wake time after sleep onset -Sleep status: lights-out time, lights-on time, total recording time, sleep-onset time, sleep-median time, final wake-up, time on the floor after final wake-up, total sleep time, sleep stage duration, sleep stage occurrence rate, and REM latency.
Secondary Outcome Measures
NameTimeMethod
-Sleep Questionnaire: OSA-MA, Pre-Sleep Questionnaire (PSQ) -HSP-70 expression in blood cells -Adverse events -Subjects' logbooks
© Copyright 2025. All Rights Reserved by MedPath